WallStreetZenWallStreetZen

NASDAQ: NMRD
Nemaura Medical Inc Stock

$1.40-0.03 (-2.1%)
Updated Feb 3, 2023
NMRD Price
$1.40
Fair Value Price
$1.82
Market Cap
$33.74M
52 Week Low
$1.27
52 Week High
$4.58
P/E
-2.19x
P/B
-3.74x
P/S
86.75x
PEG
N/A
Dividend Yield
N/A
Revenue
$577.93k
Earnings
-$15.11M
Gross Margin
27.9%
Operating Margin
-1,560.96%
Profit Margin
-2,613.9%
Debt to Equity
-2.77
Operating Cash Flow
-$8M
Beta
0.35
Next Earnings
Feb 9, 2023
Ex-Dividend
N/A
Next Dividend
N/A

NMRD Overview

Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.

Zen Score

Industry Average (30)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how NMRD scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

NMRD ($1.40) is undervalued by 23.05% relative to our estimate of its Fair Value price of $1.82 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
NMRD ($1.40) is significantly undervalued by 23.05% relative to our estimate of its Fair Value price of $1.82 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
NMRD is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more NMRD due diligence checks available for Premium users.

Be the first to know about important NMRD news, forecast changes, insider trades & much more!

NMRD News

Valuation

NMRD fair value

Fair Value of NMRD stock based on Discounted Cash Flow (DCF)
Price
$1.40
Fair Value
$1.82
Undervalued by
23.05%
NMRD ($1.40) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
NMRD ($1.40) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
NMRD is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

NMRD price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-2.19x
Industry
59.96x
Market
15.09x

NMRD price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
-3.74x
Industry
3.75x

NMRD's financial health

Profit margin

Revenue
$74.0k
Net Income
-$4.1M
Profit Margin
-5,509.4%
NMRD's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
NMRD's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$15.9M
Liabilities
$24.9M
Debt to equity
-2.77
NMRD's short-term liabilities ($20.47M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
NMRD's short-term assets ($13.95M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
NMRD's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
NMRD's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$2.2M
Investing
-$163.5k
Financing
-$1.5M
NMRD's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

NMRD vs Medical Device Stocks

TickerMarket Cap1d %P/EP/B
NMRD$33.74M-2.10%-2.19x-3.74x
TLIS$33.99M-0.99%-0.18x0.22x
LNSR$35.05M+0.63%-1.49x0.82x
DCTH$31.47M+4.27%-0.97x-6.00x
POCI$37.72M+0.60%-111.50x4.20x

Nemaura Medical Stock FAQ

What is Nemaura Medical's quote symbol?

NASDAQ: NMRD) Nemaura Medical trades on the NASDAQ under the ticker symbol NMRD. Nemaura Medical stock quotes can also be displayed as NASDAQ: NMRD.

If you're new to stock investing, here's how to buy Nemaura Medical stock.

What is the 52 week high and low for Nemaura Medical (NASDAQ: NMRD)?

(NASDAQ: NMRD) Nemaura Medical's 52-week high was $4.58, and its 52-week low was $1.27. It is currently -69.41% from its 52-week high and 10.24% from its 52-week low.

How much is Nemaura Medical stock worth today?

(NASDAQ: NMRD) Nemaura Medical currently has 24,103,196 outstanding shares. With Nemaura Medical stock trading at $1.40 per share, the total value of Nemaura Medical stock (market capitalization) is $33.74M.

Nemaura Medical stock was originally listed at a price of $25.00 in Dec 18, 2014. If you had invested in Nemaura Medical stock at $25.00, your return over the last 8 years would have been -94.4%, for an annualized return of -30.25% (not including any dividends or dividend reinvestments).

How much is Nemaura Medical's stock price per share?

(NASDAQ: NMRD) Nemaura Medical stock price per share is $1.40 today (as of Feb 3, 2023).

What is Nemaura Medical's Market Cap?

(NASDAQ: NMRD) Nemaura Medical's market cap is $33.74M, as of Feb 6, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Nemaura Medical's market cap is calculated by multiplying NMRD's current stock price of $1.40 by NMRD's total outstanding shares of 24,103,196.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.